Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;105:816-822
Published online before print January 22, 2002, doi: 10.1161/hc0702.104183
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
105/7/816    most recent
hc0702.104183v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Basta, G.
Right arrow Articles by De Caterina, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Basta, G.
Right arrow Articles by De Caterina, R.
Related Collections
Right arrow Pathophysiology
Right arrow Other diabetes

(Circulation. 2002;105:816.)
© 2002 American Heart Association, Inc.


Clinical Investigation and Reports

Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE

A Mechanism for Amplification of Inflammatory Responses

Giuseppina Basta, DBiol; Guido Lazzerini, BSc; Marika Massaro, PhD; Tommaso Simoncini, MD, PhD; Piero Tanganelli, MD; Caifeng Fu, MD; Thomas Kislinger, PhD; David M. Stern, MD; Ann Marie Schmidt, MD; Raffaele De Caterina, MD, PhD

From CNR Institute of Clinical Physiology, Pisa, Italy (G.B., G.L., M.M., T.S., R.D.C.); Institute of Pathology, University of Siena, Siena, Italy (P.T.); G. d’Annunzio University, Chieti, Italy (R.D.C.); and College of Physicians and Surgeons, Columbia University, New York, NY (C.F., T.K., D.M.S., A.M.S.).

Correspondence to Raffaele De Caterina, MD, PhD, University Cardiology Division, G. d’Annunzio University of Chieti, Ospedale S Camillo de Lellis, Via Forlanini, 50, I–66100 Chieti, Italy. E-mail rdecater{at}unich.it

Background The products of nonenzymatic glycation and oxidation of proteins, the advanced glycation end products (AGEs), form under diverse circumstances such as aging, diabetes, and kidney failure. Recent studies suggested that AGEs may form in inflamed foci, driven by oxidation or the myeloperoxidase pathway. A principal means by which AGEs alter cellular properties is through interaction with their signal-transduction receptor RAGE. We tested the hypothesis that interaction of AGEs with RAGE on endothelial cells enhances vascular activation.

Methods and Results AGEs, RAGE, vascular cell adhesion molecule-1, intercellular adhesion molecule-1, and E-selectin are expressed in an overlapping manner in human inflamed rheumatoid synovia, especially within the endothelium. In primary cultures of human saphenous vein endothelial cells, engagement of RAGE by heterogeneous AGEs or N{epsilon}(carboxymethyl)lysine–modified adducts enhanced levels of mRNA and antigen for vascular cell adhesion molecule-1, intercellular adhesion molecule-1, and E-selectin. AGEs increased adhesion of polymorphonuclear leukocytes to stimulated endothelial cells in a manner reduced on blockade of RAGE.

Conclusions AGEs, through RAGE, may prime proinflammatory mechanisms in endothelial cells, thereby amplifying proinflammatory mechanisms in atherogenesis and chronic inflammatory disorders.


Key Words: cell adhesion molecules • receptors • endothelium • inflammation • vasculature




This article has been cited by other articles:


Home page
GlycobiologyHome page
M. E. Rubio-Ruiz, E. Diaz-Diaz, M. Cardenas-Leon, R. Arguelles-Medina, P. Sanchez-Canales, F. Larrea-Gallo, E. Soria-Castro, and V. Guarner-Lans
Glycation does not modify bovine serum albumin (BSA)-induced reduction of rat aortic relaxation: The response to glycated and nonglycated BSA is lost in metabolic syndrome
Glycobiology, July 1, 2008; 18(7): 517 - 525.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
I. C. Burckhardt, D. Gozal, E. Dayyat, Y. Cheng, R. C. Li, A. D. Goldbart, and B. W. Row
Green Tea Catechin Polyphenols Attenuate Behavioral and Oxidative Responses to Intermittent Hypoxia
Am. J. Respir. Crit. Care Med., May 15, 2008; 177(10): 1135 - 1141.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
L. P. Kihm, D. Wibisono, S. Muller-Krebs, F. Pfisterer, C. Morath, M. L. Gross, M. Morcos, Y. Seregin, A. Bierhaus, P. P. Nawroth, et al.
RAGE expression in the human peritoneal membrane
Nephrol. Dial. Transplant., May 13, 2008; (2008) gfn272v1.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
W. Cai, J. C. He, L. Zhu, X. Chen, G. E. Striker, and H. Vlassara
AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66shc-dependent FKHRL1 phosphorylation
Am J Physiol Cell Physiol, January 1, 2008; 294(1): C145 - C152.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Moser, D. D. Desai, M. P. Downie, Y. Chen, S. F. Yan, K. Herold, A. M. Schmidt, and R. Clynes
Receptor for Advanced Glycation End Products Expression on T Cells Contributes to Antigen-Specific Cellular Expansion In Vivo
J. Immunol., December 15, 2007; 179(12): 8051 - 8058.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
K. de Leeuw, R. Graaff, R. de Vries, R. P. Dullaart, A. J. Smit, C. G. Kallenberg, and M. Bijl
Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus
Rheumatology, October 1, 2007; 46(10): 1551 - 1556.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
W. Cai, J. C. He, L. Zhu, X. Chen, S. Wallenstein, G. E. Striker, and H. Vlassara
Reduced Oxidant Stress and Extended Lifespan in Mice Exposed to a Low Glycotoxin Diet: Association with Increased AGER1 Expression
Am. J. Pathol., June 1, 2007; 170(6): 1893 - 1902.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Zen, C. X.-J. Chen, Y.-T. Chen, R. Wilton, and Y. Liu
Receptor for Advanced Glycation Endproducts Mediates Neutrophil Migration across Intestinal Epithelium
J. Immunol., February 15, 2007; 178(4): 2483 - 2490.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Cuccurullo, A. Iezzi, M. L. Fazia, D. De Cesare, A. Di Francesco, R. Muraro, R. Bei, S. Ucchino, F. Spigonardo, F. Chiarelli, et al.
Suppression of Rage as a Basis of Simvastatin-Dependent Plaque Stabilization in Type 2 Diabetes
Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2716 - 2723.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Poliseno, A. Tuccoli, L. Mariani, M. Evangelista, L. Citti, K. Woods, A. Mercatanti, S. Hammond, and G. Rainaldi
MicroRNAs modulate the angiogenic properties of HUVECs
Blood, November 1, 2006; 108(9): 3068 - 3071.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Fujita, H. Okuda, O. Tsukamoto, Y. Asano, Y. L. A. Hirata, J. Kim, T. Miyatsuka, S. Takashima, T. Minamino, H. Tomoike, et al.
Blockade of Angiotensin II Receptors Reduces the Expression of Receptors for Advanced Glycation End Products in Human Endothelial Cells
Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): e138 - e139.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Y. Zhong, S.-H. Li, S.-M. Liu, P. E. Szmitko, X.-Q. He, P. W.M. Fedak, and S. Verma
C-Reactive Protein Upregulates Receptor for Advanced Glycation End Products Expression in Human Endothelial Cells
Hypertension, September 1, 2006; 48(3): 504 - 511.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Goldin, J. A. Beckman, A. M. Schmidt, and M. A. Creager
Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury
Circulation, August 8, 2006; 114(6): 597 - 605.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. Shoji, H. Koyama, T. Morioka, S. Tanaka, A. Kizu, K. Motoyama, K. Mori, S. Fukumoto, A. Shioi, N. Shimogaito, et al.
Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.
Diabetes, August 1, 2006; 55(8): 2245 - 2255.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. J. Goldberg and H. M. Dansky
Diabetic Vascular Disease: An Experimental Objective
Arterioscler. Thromb. Vasc. Biol., August 1, 2006; 26(8): 1693 - 1701.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
A. G. Huebschmann, J. G. Regensteiner, H. Vlassara, and J. E.B. Reusch
Diabetes and Advanced Glycoxidation End Products.
Diabetes Care, June 1, 2006; 29(6): 1420 - 1432.
[Full Text] [PDF]


Home page
AM J ALZHEIMERS DIS OTHER DEMENHome page
T. Sato, N. Shimogaito, X. Wu, S. Kikuchi, S.-i. Yamagishi, and M. Takeuchi
Toxic Advanced Glycation End Products (TAGE) Theory in Alzheimer's Disease
American Journal of Alzheimer's Disease and Other Dementias, May 1, 2006; 21(3): 197 - 208.
[Abstract] [PDF]


Home page
JEMHome page
Z. Zhou, D. Immel, C.-X. Xi, A. Bierhaus, X. Feng, L. Mei, P. Nawroth, D. M. Stern, and W.-C. Xiong
Regulation of osteoclast function and bone mass by RAGE
J. Exp. Med., April 17, 2006; 203(4): 1067 - 1080.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. Tedgui and Z. Mallat
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Physiol Rev, April 1, 2006; 86(2): 515 - 581.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R. De Caterina, A. Zampolli, S. Del Turco, R. Madonna, and M. Massaro
Nutritional mechanisms that influence cardiovascular disease
Am. J. Clinical Nutrition, February 1, 2006; 83(2): 421S - 426S.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. Galkina and K. Ley
Leukocyte Recruitment and Vascular Injury in Diabetic Nephropathy
J. Am. Soc. Nephrol., February 1, 2006; 17(2): 368 - 377.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
V. Schwenger, C. Morath, A. Salava, K. Amann, Y. Seregin, R. Deppisch, E. Ritz, A. Bierhaus, P. P. Nawroth, and M. Zeier
Damage to the Peritoneal Membrane by Glucose Degradation Products Is Mediated by the Receptor for Advanced Glycation End-Products
J. Am. Soc. Nephrol., January 1, 2006; 17(1): 199 - 207.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. J. Goldschmidt-Clermont, M. A. Creager, D. W. Lorsordo, G. K.W. Lam, M. Wassef, and V. J. Dzau
Atherosclerosis 2005: Recent Discoveries and Novel Hypotheses
Circulation, November 22, 2005; 112(21): 3348 - 3353.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. M. Bohlender, S. Franke, G. Stein, and G. Wolf
Advanced glycation end products and the kidney
Am J Physiol Renal Physiol, October 1, 2005; 289(4): F645 - F659.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Basta, G. Lazzerini, S. Del Turco, G. M. Ratto, A. M. Schmidt, and R. De Caterina
At Least 2 Distinct Pathways Generating Reactive Oxygen Species Mediate Vascular Cell Adhesion Molecule-1 Induction by Advanced Glycation End Products
Arterioscler. Thromb. Vasc. Biol., July 1, 2005; 25(7): 1401 - 1407.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
F. Y. Chow, D. J. Nikolic-Paterson, E. Ozols, R. C. Atkins, and G. H. Tesch
Intercellular Adhesion Molecule-1 Deficiency Is Protective against Nephropathy in Type 2 Diabetic db/db Mice
J. Am. Soc. Nephrol., June 1, 2005; 16(6): 1711 - 1722.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
C. M. Ross
RE: "Carbohydrate Intake, Glycemic Index, Glycemic Load, and Dietary Fiber in Relation to Risk of Stroke in Women"
Am. J. Epidemiol., May 15, 2005; 161(10): 995 - 995.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
B. Bartling, H.-S. Hofmann, B. Weigle, R.-E. Silber, and A. Simm
Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma
Carcinogenesis, February 1, 2005; 26(2): 293 - 301.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. A. Howes, Y. Liu, J. L. Dunaief, A. Milam, J. M. Frederick, A. Marks, and W. Baehr
Receptor for Advanced Glycation End Products and Age-Related Macular Degeneration
Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3713 - 3720.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
N. Marx, D. Walcher, N. Ivanova, K. Rautzenberg, A. Jung, R. Friedl, V. Hombach, R. de Caterina, G. Basta, M.-P. Wautier, et al.
Thiazolidinediones Reduce Endothelial Expression of Receptors for Advanced Glycation End Products
Diabetes, October 1, 2004; 53(10): 2662 - 2668.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Basta, A. M. Schmidt, and R. De Caterina
Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes
Cardiovasc Res, September 1, 2004; 63(4): 582 - 592.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Lu, J. C. He, W. Cai, H. Liu, L. Zhu, and H. Vlassara
Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells
PNAS, August 10, 2004; 101(32): 11767 - 11772.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J.-L. Wautier and A. M. Schmidt
Protein Glycation: A Firm Link to Endothelial Cell Dysfunction
Circ. Res., August 6, 2004; 95(3): 233 - 238.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. C. Mamputu and G. Renier
Advanced glycation end-products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factor-induced ICAM-1 expression: inhibitory effect of antioxidants
J. Leukoc. Biol., June 1, 2004; 75(6): 1062 - 1069.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Greenway, R. J. van Suylen, G. Du Marchie Sarvaas, E. Kwan, N. Ambartsumian, E. Lukanidin, and M. Rabinovitch
S100A4/Mts1 Produces Murine Pulmonary Artery Changes Resembling Plexogenic Arteriopathy and Is Increased in Human Plexogenic Arteriopathy
Am. J. Pathol., January 1, 2004; 164(1): 253 - 262.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
D. Foell, D. Kane, B. Bresnihan, T. Vogl, W. Nacken, C. Sorg, O. FitzGerald, and J. Roth
Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis
Rheumatology, November 1, 2003; 42(11): 1383 - 1389.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Cipollone, A. Iezzi, M. Fazia, M. Zucchelli, B. Pini, C. Cuccurullo, D. De Cesare, G. De Blasis, R. Muraro, R. Bei, et al.
The Receptor RAGE as a Progression Factor Amplifying Arachidonate-Dependent Inflammatory and Proteolytic Response in Human Atherosclerotic Plaques: Role of Glycemic Control
Circulation, September 2, 2003; 108(9): 1070 - 1077.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. Zhang, A. Zalewski, Y. Liu, T. Mazurek, S. Cowan, J. L. Martin, S. M. Hofmann, H. Vlassara, and Y. Shi
Diabetes-Induced Oxidative Stress and Low-Grade Inflammation in Porcine Coronary Arteries
Circulation, July 29, 2003; 108(4): 472 - 478.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Basta, L. Venneri, G. Lazzerini, E. Pasanisi, M. Pianelli, N. Vesentini, S. Del Turco, C. Kusmic, and E. Picano
In vitro modulation of intracellular oxidative stress of endothelial cells by diagnostic cardiac ultrasound
Cardiovasc Res, April 1, 2003; 58(1): 156 - 161.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
M. Laakso and J. Kuusisto
Diabetology for cardiologists
Eur. Heart J. Suppl., January 1, 2003; 5(suppl_B): B5 - B13.
[Abstract] [PDF]


Home page
Eur Heart J SupplHome page
R. De Caterina and C. Manes
Inflammation in early atherogenesis: impact of ACE inhibition
Eur. Heart J. Suppl., January 1, 2003; 5(suppl_A): A15 - A24.
[Abstract] [PDF]


Home page
Vasc MedHome page
F. L Ruberg and J. Loscalzo
Prothrombotic determinants of coronary atherothrombosis
Vascular Medicine, November 1, 2002; 7(4): 289 - 299.
[Abstract] [PDF]


Home page
Circ. Res.Home page
W. Che, N. Lerner-Marmarosh, Q. Huang, M. Osawa, S. Ohta, M. Yoshizumi, M. Glassman, J.-D. Lee, C. Yan, B. C. Berk, et al.
Insulin-Like Growth Factor-1 Enhances Inflammatory Responses in Endothelial Cells: Role of Gab1 and MEKK3 in TNF-{alpha}-Induced c-Jun and NF-{kappa}B Activation and Adhesion Molecule Expression
Circ. Res., June 14, 2002; 90(11): 1222 - 1230.
[Abstract] [Full Text] [PDF]